カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のラベタロール市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Labetalol Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19442）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19442
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のラベタロール市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ラベタロール市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のラベタロールの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ラベタロール市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・100mg、200mg

用途別セグメントは次のように区分されます。
・病院、ドラッグストア

世界のラベタロール市場の主要な市場プレーヤーは以下のとおりです。
・Athem、Cadila Pharms、Heritage Pharma、Innogenix、Par Form、Novartis、Twi Pharms、Watson Labs、Zydus Pharms、Cnty Line Pharms、Apothecon、Bedford Laboratories、Claris Lifesciences、Pfizer、Taylor Pharmaceuticals、Sagent Strides、Schering-Plough、Prometheus Biosciences、Teva

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ラベタロール製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なラベタロールメーカーの企業概要、2019年～2022年までのラベタロールの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なラベタロールメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ラベタロールの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのラベタロールの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのラベタロール市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびラベタロールの産業チェーンを掲載しています。
・第13、14、15章では、ラベタロールの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ラベタロールの概要
- 種類別分析（2017年vs2021年vs2028年）：100mg、200mg
- 用途別分析（2017年vs2021年vs2028年）：病院、ドラッグストア
- 世界のラベタロール市場規模・予測
- 世界のラベタロール生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Athem、Cadila Pharms、Heritage Pharma、Innogenix、Par Form、Novartis、Twi Pharms、Watson Labs、Zydus Pharms、Cnty Line Pharms、Apothecon、Bedford Laboratories、Claris Lifesciences、Pfizer、Taylor Pharmaceuticals、Sagent Strides、Schering-Plough、Prometheus Biosciences、Teva
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：100mg、200mg
・用途別分析2017年-2028年：病院、ドラッグストア
・ラベタロールの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ラベタロールのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ラベタロールのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ラベタロールの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ラベタロールの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Labetalol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Labetalol market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Labetalol global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 100mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Labetalol include Athem, Cadila Pharms, Heritage Pharma, Innogenix, and Par Form, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Labetalol market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100mg
200mg
Market segment by Application can be divided into
Hospital
Drug Store
The key market players for global Labetalol market are listed below:
Athem
Cadila Pharms
Heritage Pharma
Innogenix
Par Form
Novartis
Twi Pharms
Watson Labs
Zydus Pharms
Cnty Line Pharms
Apothecon
Bedford Laboratories
Claris Lifesciences
Pfizer
Taylor Pharmaceuticals
Sagent Strides
Schering-Plough
Prometheus Biosciences
Teva
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Labetalol product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Labetalol, with price, sales, revenue and global market share of Labetalol from 2019 to 2022.
Chapter 3, the Labetalol competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Labetalol breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Labetalol market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Labetalol.
Chapter 13, 14, and 15, to describe Labetalol sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Labetalol Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Labetalol Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 100mg
1.2.3 200mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Labetalol Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Labetalol Market Size & Forecast
1.4.1 Global Labetalol Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Labetalol Sales in Volume (2017-2028)
1.4.3 Global Labetalol Price (2017-2028)
1.5 Global Labetalol Production Capacity Analysis
1.5.1 Global Labetalol Total Production Capacity (2017-2028)
1.5.2 Global Labetalol Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Labetalol Market Drivers
1.6.2 Labetalol Market Restraints
1.6.3 Labetalol Trends Analysis
2 Manufacturers Profiles
2.1 Athem
2.1.1 Athem Details
2.1.2 Athem Major Business
2.1.3 Athem Labetalol Product and Services
2.1.4 Athem Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Cadila Pharms
2.2.1 Cadila Pharms Details
2.2.2 Cadila Pharms Major Business
2.2.3 Cadila Pharms Labetalol Product and Services
2.2.4 Cadila Pharms Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Heritage Pharma
2.3.1 Heritage Pharma Details
2.3.2 Heritage Pharma Major Business
2.3.3 Heritage Pharma Labetalol Product and Services
2.3.4 Heritage Pharma Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Innogenix
2.4.1 Innogenix Details
2.4.2 Innogenix Major Business
2.4.3 Innogenix Labetalol Product and Services
2.4.4 Innogenix Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Par Form
2.5.1 Par Form Details
2.5.2 Par Form Major Business
2.5.3 Par Form Labetalol Product and Services
2.5.4 Par Form Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Labetalol Product and Services
2.6.4 Novartis Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Twi Pharms
2.7.1 Twi Pharms Details
2.7.2 Twi Pharms Major Business
2.7.3 Twi Pharms Labetalol Product and Services
2.7.4 Twi Pharms Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Watson Labs
2.8.1 Watson Labs Details
2.8.2 Watson Labs Major Business
2.8.3 Watson Labs Labetalol Product and Services
2.8.4 Watson Labs Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Zydus Pharms
2.9.1 Zydus Pharms Details
2.9.2 Zydus Pharms Major Business
2.9.3 Zydus Pharms Labetalol Product and Services
2.9.4 Zydus Pharms Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Cnty Line Pharms
2.10.1 Cnty Line Pharms Details
2.10.2 Cnty Line Pharms Major Business
2.10.3 Cnty Line Pharms Labetalol Product and Services
2.10.4 Cnty Line Pharms Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Apothecon
2.11.1 Apothecon Details
2.11.2 Apothecon Major Business
2.11.3 Apothecon Labetalol Product and Services
2.11.4 Apothecon Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bedford Laboratories
2.12.1 Bedford Laboratories Details
2.12.2 Bedford Laboratories Major Business
2.12.3 Bedford Laboratories Labetalol Product and Services
2.12.4 Bedford Laboratories Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Claris Lifesciences
2.13.1 Claris Lifesciences Details
2.13.2 Claris Lifesciences Major Business
2.13.3 Claris Lifesciences Labetalol Product and Services
2.13.4 Claris Lifesciences Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business
2.14.3 Pfizer Labetalol Product and Services
2.14.4 Pfizer Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Taylor Pharmaceuticals
2.15.1 Taylor Pharmaceuticals Details
2.15.2 Taylor Pharmaceuticals Major Business
2.15.3 Taylor Pharmaceuticals Labetalol Product and Services
2.15.4 Taylor Pharmaceuticals Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Sagent Strides
2.16.1 Sagent Strides Details
2.16.2 Sagent Strides Major Business
2.16.3 Sagent Strides Labetalol Product and Services
2.16.4 Sagent Strides Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Schering-Plough
2.17.1 Schering-Plough Details
2.17.2 Schering-Plough Major Business
2.17.3 Schering-Plough Labetalol Product and Services
2.17.4 Schering-Plough Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Prometheus Biosciences
2.18.1 Prometheus Biosciences Details
2.18.2 Prometheus Biosciences Major Business
2.18.3 Prometheus Biosciences Labetalol Product and Services
2.18.4 Prometheus Biosciences Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Teva
2.19.1 Teva Details
2.19.2 Teva Major Business
2.19.3 Teva Labetalol Product and Services
2.19.4 Teva Labetalol Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Labetalol Breakdown Data by Manufacturer
3.1 Global Labetalol Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Labetalol Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Labetalol
3.4 Market Concentration Rate
3.4.1 Top 3 Labetalol Manufacturer Market Share in 2021
3.4.2 Top 6 Labetalol Manufacturer Market Share in 2021
3.5 Global Labetalol Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Labetalol Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Labetalol Market Size by Region
4.1.1 Global Labetalol Sales in Volume by Region (2017-2028)
4.1.2 Global Labetalol Revenue by Region (2017-2028)
4.2 North America Labetalol Revenue (2017-2028)
4.3 Europe Labetalol Revenue (2017-2028)
4.4 Asia-Pacific Labetalol Revenue (2017-2028)
4.5 South America Labetalol Revenue (2017-2028)
4.6 Middle East and Africa Labetalol Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Labetalol Sales in Volume by Type (2017-2028)
5.2 Global Labetalol Revenue by Type (2017-2028)
5.3 Global Labetalol Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Labetalol Sales in Volume by Application (2017-2028)
6.2 Global Labetalol Revenue by Application (2017-2028)
6.3 Global Labetalol Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Labetalol Sales by Type (2017-2028)
7.2 North America Labetalol Sales by Application (2017-2028)
7.3 North America Labetalol Market Size by Country
7.3.1 North America Labetalol Sales in Volume by Country (2017-2028)
7.3.2 North America Labetalol Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Labetalol Sales by Type (2017-2028)
8.2 Europe Labetalol Sales by Application (2017-2028)
8.3 Europe Labetalol Market Size by Country
8.3.1 Europe Labetalol Sales in Volume by Country (2017-2028)
8.3.2 Europe Labetalol Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Labetalol Sales by Type (2017-2028)
9.2 Asia-Pacific Labetalol Sales by Application (2017-2028)
9.3 Asia-Pacific Labetalol Market Size by Region
9.3.1 Asia-Pacific Labetalol Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Labetalol Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Labetalol Sales by Type (2017-2028)
10.2 South America Labetalol Sales by Application (2017-2028)
10.3 South America Labetalol Market Size by Country
10.3.1 South America Labetalol Sales in Volume by Country (2017-2028)
10.3.2 South America Labetalol Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Labetalol Sales by Type (2017-2028)
11.2 Middle East & Africa Labetalol Sales by Application (2017-2028)
11.3 Middle East & Africa Labetalol Market Size by Country
11.3.1 Middle East & Africa Labetalol Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Labetalol Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Labetalol and Key Manufacturers
12.2 Manufacturing Costs Percentage of Labetalol
12.3 Labetalol Production Process
12.4 Labetalol Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Labetalol Typical Distributors
13.3 Labetalol Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Labetalol Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Labetalol Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Athem Basic Information, Manufacturing Base and Competitors
Table 4. Athem Major Business
Table 5. Athem Labetalol Product and Services
Table 6. Athem Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Cadila Pharms Basic Information, Manufacturing Base and Competitors
Table 8. Cadila Pharms Major Business
Table 9. Cadila Pharms Labetalol Product and Services
Table 10. Cadila Pharms Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Heritage Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Heritage Pharma Major Business
Table 13. Heritage Pharma Labetalol Product and Services
Table 14. Heritage Pharma Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Innogenix Basic Information, Manufacturing Base and Competitors
Table 16. Innogenix Major Business
Table 17. Innogenix Labetalol Product and Services
Table 18. Innogenix Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Par Form Basic Information, Manufacturing Base and Competitors
Table 20. Par Form Major Business
Table 21. Par Form Labetalol Product and Services
Table 22. Par Form Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Labetalol Product and Services
Table 26. Novartis Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Twi Pharms Basic Information, Manufacturing Base and Competitors
Table 28. Twi Pharms Major Business
Table 29. Twi Pharms Labetalol Product and Services
Table 30. Twi Pharms Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Watson Labs Basic Information, Manufacturing Base and Competitors
Table 32. Watson Labs Major Business
Table 33. Watson Labs Labetalol Product and Services
Table 34. Watson Labs Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Zydus Pharms Basic Information, Manufacturing Base and Competitors
Table 36. Zydus Pharms Major Business
Table 37. Zydus Pharms Labetalol Product and Services
Table 38. Zydus Pharms Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Cnty Line Pharms Basic Information, Manufacturing Base and Competitors
Table 40. Cnty Line Pharms Major Business
Table 41. Cnty Line Pharms Labetalol Product and Services
Table 42. Cnty Line Pharms Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Apothecon Basic Information, Manufacturing Base and Competitors
Table 44. Apothecon Major Business
Table 45. Apothecon Labetalol Product and Services
Table 46. Apothecon Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Bedford Laboratories Basic Information, Manufacturing Base and Competitors
Table 48. Bedford Laboratories Major Business
Table 49. Bedford Laboratories Labetalol Product and Services
Table 50. Bedford Laboratories Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Claris Lifesciences Basic Information, Manufacturing Base and Competitors
Table 52. Claris Lifesciences Major Business
Table 53. Claris Lifesciences Labetalol Product and Services
Table 54. Claris Lifesciences Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer Labetalol Product and Services
Table 58. Pfizer Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Taylor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Taylor Pharmaceuticals Major Business
Table 61. Taylor Pharmaceuticals Labetalol Product and Services
Table 62. Taylor Pharmaceuticals Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Sagent Strides Basic Information, Manufacturing Base and Competitors
Table 64. Sagent Strides Major Business
Table 65. Sagent Strides Labetalol Product and Services
Table 66. Sagent Strides Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Schering-Plough Basic Information, Manufacturing Base and Competitors
Table 68. Schering-Plough Major Business
Table 69. Schering-Plough Labetalol Product and Services
Table 70. Schering-Plough Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Prometheus Biosciences Basic Information, Manufacturing Base and Competitors
Table 72. Prometheus Biosciences Major Business
Table 73. Prometheus Biosciences Labetalol Product and Services
Table 74. Prometheus Biosciences Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Teva Basic Information, Manufacturing Base and Competitors
Table 76. Teva Major Business
Table 77. Teva Labetalol Product and Services
Table 78. Teva Labetalol Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Labetalol Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 80. Global Labetalol Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Labetalol, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Labetalol Production Capacity by Company, (K Units): 2020 VS 2021
Table 83. Head Office and Labetalol Production Site of Key Manufacturer
Table 84. Labetalol New Entrant and Capacity Expansion Plans
Table 85. Labetalol Mergers & Acquisitions in the Past Five Years
Table 86. Global Labetalol Sales by Region (2017-2022) & (K Units)
Table 87. Global Labetalol Sales by Region (2023-2028) & (K Units)
Table 88. Global Labetalol Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Labetalol Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Labetalol Sales by Type (2017-2022) & (K Units)
Table 91. Global Labetalol Sales by Type (2023-2028) & (K Units)
Table 92. Global Labetalol Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Labetalol Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Labetalol Price by Type (2017-2022) & (US$/Unit)
Table 95. Global Labetalol Price by Type (2023-2028) & (US$/Unit)
Table 96. Global Labetalol Sales by Application (2017-2022) & (K Units)
Table 97. Global Labetalol Sales by Application (2023-2028) & (K Units)
Table 98. Global Labetalol Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Labetalol Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Labetalol Price by Application (2017-2022) & (US$/Unit)
Table 101. Global Labetalol Price by Application (2023-2028) & (US$/Unit)
Table 102. North America Labetalol Sales by Country (2017-2022) & (K Units)
Table 103. North America Labetalol Sales by Country (2023-2028) & (K Units)
Table 104. North America Labetalol Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Labetalol Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Labetalol Sales by Type (2017-2022) & (K Units)
Table 107. North America Labetalol Sales by Type (2023-2028) & (K Units)
Table 108. North America Labetalol Sales by Application (2017-2022) & (K Units)
Table 109. North America Labetalol Sales by Application (2023-2028) & (K Units)
Table 110. Europe Labetalol Sales by Country (2017-2022) & (K Units)
Table 111. Europe Labetalol Sales by Country (2023-2028) & (K Units)
Table 112. Europe Labetalol Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Labetalol Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Labetalol Sales by Type (2017-2022) & (K Units)
Table 115. Europe Labetalol Sales by Type (2023-2028) & (K Units)
Table 116. Europe Labetalol Sales by Application (2017-2022) & (K Units)
Table 117. Europe Labetalol Sales by Application (2023-2028) & (K Units)
Table 118. Asia-Pacific Labetalol Sales by Region (2017-2022) & (K Units)
Table 119. Asia-Pacific Labetalol Sales by Region (2023-2028) & (K Units)
Table 120. Asia-Pacific Labetalol Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Labetalol Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Labetalol Sales by Type (2017-2022) & (K Units)
Table 123. Asia-Pacific Labetalol Sales by Type (2023-2028) & (K Units)
Table 124. Asia-Pacific Labetalol Sales by Application (2017-2022) & (K Units)
Table 125. Asia-Pacific Labetalol Sales by Application (2023-2028) & (K Units)
Table 126. South America Labetalol Sales by Country (2017-2022) & (K Units)
Table 127. South America Labetalol Sales by Country (2023-2028) & (K Units)
Table 128. South America Labetalol Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Labetalol Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Labetalol Sales by Type (2017-2022) & (K Units)
Table 131. South America Labetalol Sales by Type (2023-2028) & (K Units)
Table 132. South America Labetalol Sales by Application (2017-2022) & (K Units)
Table 133. South America Labetalol Sales by Application (2023-2028) & (K Units)
Table 134. Middle East & Africa Labetalol Sales by Region (2017-2022) & (K Units)
Table 135. Middle East & Africa Labetalol Sales by Region (2023-2028) & (K Units)
Table 136. Middle East & Africa Labetalol Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Labetalol Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Labetalol Sales by Type (2017-2022) & (K Units)
Table 139. Middle East & Africa Labetalol Sales by Type (2023-2028) & (K Units)
Table 140. Middle East & Africa Labetalol Sales by Application (2017-2022) & (K Units)
Table 141. Middle East & Africa Labetalol Sales by Application (2023-2028) & (K Units)
Table 142. Labetalol Raw Material
Table 143. Key Manufacturers of Labetalol Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Labetalol Typical Distributors
Table 147. Labetalol Typical Customers
List of Figures
Figure 1. Labetalol Picture
Figure 2. Global Labetalol Revenue Market Share by Type in 2021
Figure 3. 100mg
Figure 4. 200mg
Figure 5. Global Labetalol Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Global Labetalol Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Labetalol Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Labetalol Sales (2017-2028) & (K Units)
Figure 11. Global Labetalol Price (2017-2028) & (US$/Unit)
Figure 12. Global Labetalol Production Capacity (2017-2028) & (K Units)
Figure 13. Global Labetalol Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Labetalol Market Drivers
Figure 15. Labetalol Market Restraints
Figure 16. Labetalol Market Trends
Figure 17. Global Labetalol Sales Market Share by Manufacturer in 2021
Figure 18. Global Labetalol Revenue Market Share by Manufacturer in 2021
Figure 19. Labetalol Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Labetalol Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Labetalol Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Labetalol Sales Market Share by Region (2017-2028)
Figure 23. Global Labetalol Revenue Market Share by Region (2017-2028)
Figure 24. North America Labetalol Revenue (2017-2028) & (USD Million)
Figure 25. Europe Labetalol Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Labetalol Revenue (2017-2028) & (USD Million)
Figure 27. South America Labetalol Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Labetalol Revenue (2017-2028) & (USD Million)
Figure 29. Global Labetalol Sales Market Share by Type (2017-2028)
Figure 30. Global Labetalol Revenue Market Share by Type (2017-2028)
Figure 31. Global Labetalol Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Labetalol Sales Market Share by Application (2017-2028)
Figure 33. Global Labetalol Revenue Market Share by Application (2017-2028)
Figure 34. Global Labetalol Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Labetalol Sales Market Share by Type (2017-2028)
Figure 36. North America Labetalol Sales Market Share by Application (2017-2028)
Figure 37. North America Labetalol Sales Market Share by Country (2017-2028)
Figure 38. North America Labetalol Revenue Market Share by Country (2017-2028)
Figure 39. United States Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Labetalol Sales Market Share by Type (2017-2028)
Figure 43. Europe Labetalol Sales Market Share by Application (2017-2028)
Figure 44. Europe Labetalol Sales Market Share by Country (2017-2028)
Figure 45. Europe Labetalol Revenue Market Share by Country (2017-2028)
Figure 46. Germany Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Labetalol Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Labetalol Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Labetalol Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Labetalol Revenue Market Share by Region (2017-2028)
Figure 55. China Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Labetalol Sales Market Share by Type (2017-2028)
Figure 62. South America Labetalol Sales Market Share by Application (2017-2028)
Figure 63. South America Labetalol Sales Market Share by Country (2017-2028)
Figure 64. South America Labetalol Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Labetalol Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Labetalol Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Labetalol Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Labetalol Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Labetalol Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Labetalol in 2021
Figure 76. Manufacturing Process Analysis of Labetalol
Figure 77. Labetalol Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のリシノプリル市場2022年：市場規模予測（～2028年）
  • 世界のプロプラノロール塩酸塩市場2022年：市場規模予測（～2028年）
  • 世界のモノアミン酸化酵素B（MAO-B）市場2022年：市場規模予測（～2028年）
  • 世界の鼻腔内除菌キット市場2022年：市場規模予測（～2028年）
  • 世界の鼻腔内除菌薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19442 )"世界のラベタロール市場2022年：市場規模予測（～2028年）" (英文：Global Labetalol Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。